The Autus Size-Adjustable Valve, which can be expanded as children grow, may reduce the need for repeat open-heart surgeries for congenital defects.
|Articles|October 1, 1998
Supplements and Featured Publications
- Clinical and Economic Considerations of Antimicrobial Use
- Volume 4
- Issue 11 Suppl
Optimizing Antimicrobial Therapy and Emerging Pathogens
Author(s)David P. Nicolau, PharmD
Advertisement
Articles in this issue
about 28 years ago
Participating Facultyabout 28 years ago
Introductionabout 28 years ago
Mechanisms and Current Rates of Resistanceabout 28 years ago
Influence of Antibiotics on the Normal Floraabout 28 years ago
Therapeutic Pathways for Antimicrobial Use: General Overviewabout 28 years ago
Therapeutic Pathways for Antimicrobial Use: Pediatric Issuesabout 28 years ago
Pharmacoeconomic Impact of Appropriate Clinical Pathwaysabout 28 years ago
CME QuizAdvertisement
Related to this article
A scoping review of 15 studies found psoriasis prevalence markedly lower across 13 indigenous populations worldwide.
A traditional Medicare out-of-pocket (OOP) cap could reduce beneficiaries’ costs but increase annual federal spending by $39 billion to $96 billion.
A systemic sclerosis inception cohort and 17-study meta-analysis found a nearly 5-fold increase in lung cancer risk.
Medicare Advantage plans have varied motivations, strategies, and aspirations for addressing health-related social needs among home health beneficiaries, highlighting a need to expand the scope of supplemental benefits.
2026 Nobel Prize in Medicine honors optogenetics pioneers who turn algae light-sensing protein into neural switches, transforming brain mapping and enabling vision-restoration trials.
Medicare's Transforming Episode Accountability Model is projected to save $46.6 million by 2030, with safety-net hospitals potentially receiving the highest reconciliation payments.
A comparison of 2013 and 2022 data shows that cancer costs are not uniformly rising. Costs decreased for metastatic colorectal cancer but increased for both metastatic non–small cell lung cancer and multiple myeloma.
Advertisement
Advertisement
Trending on AJMC
1
Pipeline Advances in Sjögren Disease Bring Targeted Therapies Closer
2
Systemic Sclerosis Linked to Dramatic Rise in Lung Cancer Risk
3
VBC Risk Is Outpacing Provider Readiness, CMS Must Act
4
FDA Approves Pirtobrutinib for Untreated CLL/SLL Without 17p Deletion
5